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Introduction
Podocytes are kidney cells residing in the Bowman’s cap-
sule wrapping around the capillaries of the glomerulus;
they form a seal, which contributes greatly to the glomeru-
lar filtration barrier (GFB). Their function is highly linked
to their morphology, alterations result in loss of integrity
of the podocyte seal which can allow the diffusion of
proteins from the circulation resulting in proteinuria. A
human podocyte cell-line with human-monocyte derived
macrophages can be used to create an in vitro model of
lupus nephritis (LN). Using this model, it is known that
the chemokine monocyte chemoattractant protein 1
(MCP-1) may be released, which has also been identified
as a biomarker of the active disease. MCP-1 causes recruit-
ment of pro-inflammatory cells to the kidney. Incubation
of this model with JSLE serum may mediate an inflamma-
tory response representing a biologically relevant environ-
ment and subsequently provide a clearer understanding
into the development of LN.
Objectives
To determine the effect of JSLE serum on the regulation
of MCP-1 produced in a LN in vitro model.
Methods
Human monocytes were differentiated into macrophages
using media containing monocyte colony stimulating
factor. The macrophages were then either unstimulated
(inactive cells) or incubated with IFN-g (1ng/ml) or 5%
JSLE serum. After 48 hours the supernatant from the
macrophages were removed and added to mature
podocytes. MCP-1 concentration (mean±SEM) was
measured using ELISA. Images were taken using a light
microscope to allow any morphological changes in the
podocytes to be observed.
Results
Previously we have shown IFNg activated macrophages to
produce MCP-1 which in turn increases the concentration
of MCP-1 produced by podocytes, while unstimulated
macrophages show no difference. Importantly when JSLE
serum (n=4) is added to unstimulated macrophages, it
activates them in a similar manner to IFNg alone.
Incubated with JSLE serum elicited a significant increase
in MCP-1 concentration produced by the macrophages
(1357±84ng/ml) compared with unstimulated (252
±162ng/ml; p=0.0001). There was no significant difference
in MCP-1 concentration compared to IFNg activated
macrophages (1396±349ng/ml; p=0.477). When JSLE
serum stimulated macrophages are co-cultured with
podocytes, MCP-1 concentration is again found to be
significantly higher than unstimulated macrophages (2567
±87ng/ml; p=0.0002) with no significant difference with
IFNg activated macrophages (3030±289ng/ml; p=0.099).
Podocytes incubated with JSLE serum activated macro-
phages also result in dramatic changes to the podocyte
morphology which was again similar to that seen with
IFNg activated macrophages.
Conclusion
JSLE serum stimulated the macrophages in an analogous
way to IFNg, resulting in increased MCP-1 production by
both the macrophages and podocytes, suggesting that
macrophage activation by IFNg is similar to that observed
in LN. However, the concentration of MCP-1 does not
exceed that which is produced by the co-culturing of
podocytes with IFNg activated macrophages. Therefore
serum factors directly acting on the podocytes need to be
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identified. The importance of IFN’s in JSLE pathogenesis is
widely accepted however the role of the IFN subtypes in
the development of the disease is unclear. This study
provides evidence to suggest that factors in JSLE serum
such as IFNg may play a prominent role in the activity and
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